Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug:204:141-142.
doi: 10.1016/j.thromres.2021.02.030. Epub 2021 Mar 3.

Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research

Bernhard Lämmle  1 , Heidi Rossmann  2
Affiliations

Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research

Bernhard Lämmle et al. Thromb Res. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

B.L. is Chairman of the Data Safety Monitoring Committee of the BAXALTA 281102 and the SHIRE SHP655-201 studies (now both run by TAKEDA), investigating recombinant ADAMTS13 therapy in hereditary and acquired TTP, respectively. He is on the Advisory Board of Sanofi for caplacizumab, and received travel and accomodation support for participating at scientific meetings and/or lecture fees from Ablynx, Alexion, Bayer, Roche, Sanofi and Siemens.

Dataset described in

References

    1. Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronarvirus pneumonia. J. Thromb. Haemost. 2020;18:1421–1424. - PMC - PubMed
    1. Klok F.A., Kruip M.J.H.A., Van Der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M., et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. 2020;191:148–150. - PMC - PubMed
    1. Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an acedemic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. - PMC - PubMed
    1. Zhang L., Yan X., Fan Q., Liu H., Liu X., Liu Z., et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J. Thromb. Haemost. 2020;18:1324–1329. - PMC - PubMed
    1. Taylor F.B., Toh C.H., Hoots W.K., Wada H., Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 2001;86:1327–1330. - PubMed